Judgment of the General Court (Fourth Chamber) of 16 July 2014 —
Endoceutics v OHIM — Merck (FEMIVIA)

(Case T‑324/13)

Community trade mark — Opposition proceedings — Application for the Community word mark FEMIVIA — Earlier Community word mark FEMIBIO — International registration designating the European Community of the earlier figurative mark femibion — Relative ground for refusal — Likelihood of confusion — Article 8(1)(b) of Regulation (EC) No 207/2009

1.                     Community trade mark — Definition and acquisition of the Community trade mark — Relative grounds for refusal — Opposition by the proprietor of an earlier identical or similar mark registered for identical or similar goods or services — Likelihood of confusion with the earlier mark — Criteria for assessment (Council Regulation No 207/2009, Art. 8(1)(b)) (see paras 19-22, 29)

2.                     Community trade mark — Definition and acquisition of the Community trade mark — Relative grounds for refusal — Opposition by the proprietor of an earlier identical or similar mark registered for identical or similar goods or services — Likelihood of confusion with the earlier mark — Word mark FEMIVIA and figurative mark femibion (Council Regulation No 207/2009, Art. 8(1)(b)) (see paras 26-28, 45-49)

Re:

ACTION brought against the decision of the Fourth Board of Appeal of OHIM of 15 April 2013 (Case R 1021/2012-4), concerning opposition proceedings between Merck KGaA and Endoceutics, Inc.

Operative part

The Court:

1. Dismisses the action;

2. Orders Endoceutics, Inc. to pay the costs.